Regulation of macroautophagy in ovarian cancer cells in vitro and in vivo by controlling glucose regulatory protein 78 and AMPK.

Oncotarget
Prabodh K Kandala, Sanjay K Srivastava

Abstract

In this study we show that diindolylmethane (DIM) induces autophagy in ovarian cancer cells by regulating endoplasmic reticulum (ER) stress and AMPK. Treatment of SKOV-3, OVCAR-3 and TOV-21G ovarian cancer cells with varying concentrations of DIM for 24 hours resulted in a concentration dependent induction of autophagy as measured by flowcytometry. Electron microscopy confirmed the presence of autophagosomes in DIM treated cells. Western blot analysis showed that DIM treatment increased the expression of LC3B, a hall mark of autophagy as well as p62 and Atg 12 proteins that are accumulated during autophagy. Autophagy inhibitors bafilomycin or chloroquine inhibited DIM induced autophagy. Furthermore, DIM treatment significantly increased the expression of ER stress regulators such as Grp78, IRE1 and GADD153. Cycloheximide or ER stress inhibitor mithramycin not only blocked ER stress proteins that were activated by DIM but also autophagy. Silencing Grp78 or GADD 153 significantly blocked the expression of LC3B and p62 indicating that autophagy in our model is mediated by ER stress. Knocking out LC3B inhibited DIM induced autophagy. DIM treatment increased the cytosolic calcium levels which lead to the activation of AMPK in our mo...Continue Reading

References

Mar 1, 1992·Chemical Research in Toxicology·K R Grose, L F Bjeldanes
Jan 10, 2004·Cell Death and Differentiation·T KanzawaS Kondo
Apr 13, 2004·Oncogene·Devrim Gozuacik, Adi Kimchi
Oct 4, 2005·The Journal of Clinical Investigation·Chunyan XuJohn C Reed
Oct 4, 2005·The Journal of Clinical Investigation·Beth Levine, Junying Yuan
Jan 7, 2006·Cell Death and Differentiation·J Wu, R J Kaufman
Nov 15, 2006·The Journal of Cell Biology·Francesca DemarchiClaudio Schneider
Jan 25, 2007·Molecular Cell·Maria Høyer-HansenMarja Jäättelä
Jul 7, 2007·Cell Death and Differentiation·M Høyer-Hansen, M Jäättelä
Nov 2, 2007·Nature Reviews. Cancer·Robin MathewEileen White
Sep 2, 2008·Autophagy·Daniel J KlionskyDavid C Rubinsztein
Oct 10, 2008·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Gregory A ReedAryeh Hurwitz
Dec 2, 2008·Nature Reviews. Drug Discovery·Inki KimJohn C Reed
Dec 17, 2008·Cell Death and Differentiation·N Kourtis, N Tavernarakis
Jan 30, 2009·Journal of the National Cancer Institute·Ravi P Sahu, Sanjay K Srivastava
Oct 2, 2009·Nature·Yuya NishidaShigeomi Shimizu
Nov 27, 2009·Gynecologic Oncology·Giuseppe Del PrioreAlan A Arslan
Feb 11, 2010·Cell·Noboru MizushimaBeth Levine
Oct 23, 2010·Molecular Cell·Guido KroemerBeth Levine
Jan 25, 2011·Nature Cell Biology·Joungmok KimKun-Liang Guan
Feb 26, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Srinivas Reddy BoreddySanjay K Srivastava
Apr 5, 2011·The Korean Journal of Physiology & Pharmacology : Official Journal of the Korean Physiological Society and the Korean Society of Pharmacology·Youn Ju LeeChuhee Lee
May 6, 2011·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Sama F SleimanRajiv R Ratan
Aug 3, 2011·Cellular Signalling·Michelle F GreenAnthony R Means

❮ Previous
Next ❯

Citations

Mar 31, 2015·BioMed Research International·Elżbieta KaniaArkadiusz Orzechowski
Nov 9, 2016·Oncotarget·Lei ZhanBing Wei
Sep 21, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Renukadevi PatilKenneth D Beaman
Nov 16, 2017·International Journal of Oncology·Roger K ChangWeng-Onn Lui
Jul 25, 2012·BMC Medicine·Parul Gupta, Sanjay K Srivastava
May 18, 2016·Scientific Reports·Alok Ranjan, Sanjay K Srivastava
Sep 7, 2016·Oncogene·J P BernardiniG Dewson
Apr 6, 2017·Oncotarget·Alok Ranjan, Sanjay K Srivastava
Jul 8, 2020·BMC Complementary Medicine and Therapies·Ming-Liang ZhuLu Wang
Jan 9, 2013·Expert Opinion on Therapeutic Targets·Natalia PrevarskayaYaroslav Shuba
Aug 24, 2013·Cell Cycle·Yang ZhaoHua-chuan Zheng
Mar 27, 2015·Oncotarget·Weidong LiBaojin Hua
Aug 18, 2017·Journal of Cellular Biochemistry·Sam-Young ParkJi-Yeon Jung
Jun 18, 2017·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Alok RanjanSanjay K Srivastava
May 11, 2019·Experimental Cell Research·Daniel W ColeAndrew M Fribley

❮ Previous
Next ❯

Methods Mentioned

BETA
protein folding
electron microscopy
flowcytometry
xenograft
transfection
electrophoresis

Software Mentioned

Prism
GraphPad

Related Concepts

Related Feeds

Autophagy Networks

Autophagy is a lysosomal pathway that involves degradation of proteins and functions in normal growth and pathological conditions, through a series of complex networks. The catabolic process involves delivery of proteins and organelles to the lysosome. Here is the latest research on autophagy networks.

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.